abstract |
Methods for treating treatment-naive as well as treatment-experiencednpatients having melanoma to increase the progression-freensurvival time involving administering a therapeutically effective amount ofnpegylated interferon-alfa, e.g. , preferably pegylated interferon alfa-2b, asnadjuvant therapy to definitive surgery are disclosed. |